Get the Stockscreener App
7.51
1.76%
0.13
After Hours:
7.51
Evolus Inc stock is traded at $7.51, with a volume of 656.71K.
It is up +1.76% in the last 24 hours and down -17.56% over the past month.
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.
See More
Previous Close:
$7.38
Open:
$7.4
24h Volume:
656.71K
Relative Volume:
0.49
Market Cap:
$485.79M
Revenue:
$202.09M
Net Income/Loss:
$-61.69M
P/E Ratio:
-6.9537
EPS:
-1.08
Net Cash Flow:
$-35.64M
1W Performance:
-0.13%
1M Performance:
-17.56%
6M Performance:
-47.67%
1Y Performance:
-51.27%
1-Day Range:
$7.26
$7.53
1-Week Range:
$7.185
$7.665
52-Week Range:
$5.71
$17.82
Evolus Inc Stock (EOLS) Company Profile
Name
Evolus Inc
Sector
Phone
(949) 284-4555
Address
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
Compare EOLS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EOLS
Evolus Inc
|
7.51 | 485.14M | 202.09M | -61.69M | -35.64M | -1.08 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Evolus Inc Stock (EOLS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Downgrade | Needham | Buy → Hold |
| Apr-17-25 | Initiated | BTIG Research | Buy |
| Jan-29-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-23-22 | Initiated | Needham | Buy |
| May-12-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-20-22 | Upgrade | Truist | Hold → Buy |
| May-06-21 | Upgrade | Mizuho | Neutral → Buy |
| Apr-08-21 | Reiterated | H.C. Wainwright | Buy |
| Feb-24-21 | Downgrade | Truist | Buy → Hold |
| Jul-07-20 | Downgrade | Mizuho | Buy → Neutral |
| Feb-06-20 | Resumed | Mizuho | Buy |
| Nov-26-19 | Initiated | SVB Leerink | Outperform |
| Sep-05-19 | Resumed | Mizuho | Buy |
| Jun-28-19 | Initiated | Wells Fargo | Market Perform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| Mar-20-19 | Initiated | SunTrust | Buy |
| Feb-14-19 | Initiated | H.C. Wainwright | Buy |
| Jan-29-19 | Initiated | Stifel | Buy |
View All
Evolus Inc Stock (EOLS) Latest News
Is Evolus Inc. a speculative investmentQuarterly Market Summary & Long-Term Growth Plans - khodrobank.com
Has Evolus Inc. formed a bullish divergenceJuly 2025 Closing Moves & Weekly Market Pulse Alerts - Newser
Chart based analysis of Evolus Inc. trendsWeekly Loss Report & Reliable Price Breakout Alerts - Newser
Automated trading signals detected on Evolus Inc.July 2025 Pullbacks & High Accuracy Investment Signals - Newser
Tools to monitor Evolus Inc. recovery probabilityGlobal Markets & Fast Gain Stock Tips - Newser
Is Evolus Inc. stock reversal real or fake2025 Top Gainers & Technical Pattern Based Signals - Newser
Using Bollinger Bands to evaluate Evolus Inc.2025 Top Gainers & Verified Momentum Stock Alerts - Newser
How institutional ownership impacts Evolus Inc. stockTrade Risk Report & AI Driven Stock Reports - Newser
Pattern recognition hints at Evolus Inc. upsideWeekly Gains Summary & Safe Capital Allocation Plans - Newser
How moving averages guide Evolus Inc. tradingGap Down & Comprehensive Market Scan Reports - Newser
Will breakout in Evolus Inc. lead to full recovery2025 Big Picture & Real-Time Price Movement Reports - Newser
Is a relief rally coming for Evolus Inc. holders2025 Trade Ideas & Real-Time Stock Price Movement Reports - Newser
What is Evolus Inc. s 5 year growth outlook getLinesFromResByArray error: size == 0 - mustnews.co.kr
Quantitative breakdown of Evolus Inc. recent moveFed Meeting & Target Return Focused Stock Picks - Newser
Can trapped investors hope for a rebound in Evolus Inc.Market Performance Recap & Fast Gaining Stock Strategy Reports - Newser
Drawdown in Evolus Inc. May Be Nearing End getLinesFromResByArray error: size == 0 - kangso.co.kr
Trendlines Suggest Evolus Inc. May Bottom Out Soon getLinesFromResByArray error: size == 0 - 클래시안
How to interpret RSI for Evolus Inc. stockJuly 2025 News Drivers & Proven Capital Preservation Tips - Newser
Visual analytics tools that track Evolus Inc. performanceBull Run & Smart Allocation Stock Tips - Newser
Understanding Evolus Inc.’s price movementTrend Reversal & Verified Trade Idea Suggestions - Newser
Price action breakdown for Evolus Inc.Trade Analysis Summary & Weekly High Return Stock Opportunities - Newser
Has Evolus Inc. found a price floorJuly 2025 EndofMonth & Safe Entry Trade Reports - Newser
What makes Evolus Inc. stock price move sharplyJuly 2025 Sector Moves & Daily Entry Point Trade Alerts - Newser
Will Evolus Inc. bounce back from current supportChart Signals & Safe Entry Momentum Tips - Newser
What indicators show strength in Evolus Inc.Portfolio Return Report & Technical Confirmation Trade Alerts - Newser
Evolus announces Evolysse Sculpt trial meets primary endpoint - MSN
Analyzing recovery setups for Evolus Inc. investorsJuly 2025 Recap & AI Powered Buy and Sell Recommendations - Newser
Evolus Inc Stock (EOLS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Evolus Inc Stock (EOLS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Stewart Brady | Director |
Aug 15 '25 |
Buy |
6.82 |
30,000 |
204,486 |
88,629 |
| MOATAZEDI DAVID | See Remarks |
Jun 13 '25 |
Sale |
10.05 |
111,323 |
1,119,141 |
381,509 |
| MOATAZEDI DAVID | See Remarks |
Jun 16 '25 |
Sale |
9.89 |
16,582 |
164,054 |
364,927 |
3.60%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):